08-Aug-2007 - Galapagos has reported a profit erosion for the first half of 2007 amidst accelerated R&D spend and business reshuffling. Meanwhile its services division has inked its third contract with AstraZeneca.
27-Nov-2006 - The search for novel drug targets for cystic fibrosis received a boost after Dutch biotechnology company Galapagos announced the extension of its alliance with Cystic Fibrosis Foundation Therapeutics (CFFT), the non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation.
02-Nov-2006 - Genomics-based drug discovery company Galapagos, has struck a deal with LEO Pharma in an agreement that will see the firm use its natural compound collection for high throughput screening, hit verification, and profiling of selected compounds for LEO Pharma's antibacterial research program.
19-Jul-2006 - Galapagos and Cellzome have announced the start of a drug discovery collaboration in which the two companies are to concentrate on kinases, a popular target for pharmaceutical therapies for cancer and inflammatory diseases.
14-Jun-2006 - Galapagos are to acquire the drug discovery service operations of Discovery Partners International for $6.4m in a move that cements Galapagos' BioFocus division as a top three provider in drug discovery services worldwide.